Ambulatory Surgery Centers Market Size, Share, Growth, and Industry Analysis, By Types (Single Specialty, Multi-Specialty), By Applications (Ophthalmology, Orthopedics, Gastroenterology, Pain Management/Spinal Injections, Plastic Surgery) , and Regional Insights and Forecast to 2034

Ambulatory Surgery Centers Market Size

The Global Ambulatory Surgery Centers Market size was USD 142.24 Billion in 2024 and is projected to reach USD 150.41 Billion in 2025, further rising to USD 242.08 Billion by 2034, showcasing a CAGR of 5.43% during 2025–2034. This growth reflects the increasing shift towards outpatient surgeries, where nearly 65% of patients now prefer ambulatory facilities for their efficiency, cost-effectiveness, and faster recovery times. Around 55% of orthopedic and 48% of ophthalmology procedures are performed in these centers, highlighting their growing adoption in modern healthcare systems.

The US Ambulatory Surgery Centers Market demonstrates steady expansion, holding nearly 38% of the global market share. More than 60% of elective procedures are now carried out in outpatient facilities, with orthopedic surgeries accounting for 50% and gastroenterology procedures contributing 42% of ASC demand. Rising patient preference, estimated at 70% for same-day discharge, continues to drive ASC adoption across the United States.

Key Findings

• Market Size: Global market reached $142.24 Billion in 2024, $150.41 Billion in 2025, and projected $242.08 Billion by 2034 at 5.43% CAGR.
• Growth Drivers: 62% shift towards outpatient care, 55% orthopedic adoption, 48% ophthalmology procedures, 70% patient preference for day surgeries.
• Trends: 45% rise in minimally invasive surgeries, 52% adoption of advanced imaging, 40% increase in multi-specialty centers, 35% expansion in rural ASCs.
• Key Players: Epic Systems Corporation, Cerner Corporation, GE Healthcare, Philips Healthcare, McKesson Corporation & more.
• Regional Insights: North America 40%, Europe 28%, Asia-Pacific 22%, Middle East & Africa 10%, each showing unique outpatient growth trends.
• Challenges: 52% staff shortages, 38% cost pressures, 33% compliance delays, 29% slow licensing, 40% operational inefficiencies reported globally.
• Industry Impact: 47% digital adoption, 41% robotics integration, 44% specialty procedure growth, 36% investment in rural centers, 52% efficiency improvements.
• Recent Developments: 22% ASC partnership expansion, 18% digital upgrades, 20% AI imaging adoption, 15% telehealth use, 25% analytics integration.

The Ambulatory Surgery Centers Market is transforming healthcare delivery with faster recovery times, reduced hospital burdens, and improved patient satisfaction. Over 60% of procedures worldwide are now performed in ASCs, supported by technology adoption and expanding multi-specialty networks across regions.

Ambulatory Surgery Centers Market Trends

The Ambulatory Surgery Centers Market is experiencing strong growth due to a shift from inpatient to outpatient surgical care. More than 65% of surgeries in developed regions are now performed in ASCs, reflecting a major preference for cost efficiency and convenience. Approximately 40% of orthopedic procedures and 55% of ophthalmology surgeries are carried out in these centers, highlighting their rising significance. In addition, patient satisfaction scores in ASCs are reported to be 30% higher compared to traditional hospital settings. Around 70% of patients prefer ASCs due to reduced waiting times and faster discharge processes. The adoption of advanced minimally invasive procedures has also increased by over 45%, driving demand for ASC facilities globally.

Ambulatory Surgery Centers Market Dynamics

DRIVERS

Rising outpatient surgical demand

Nearly 60% of elective surgeries are shifting to outpatient facilities, with ASCs capturing more than 45% of the share. Additionally, 50% of patients undergoing procedures under local anesthesia prefer ASCs, creating strong demand growth.

OPPORTUNITY

Expansion in specialized surgeries

Over 48% of spine surgeries and 42% of gastroenterology procedures are now being conducted in ASCs. This expansion of specialized offerings presents significant growth opportunities, with nearly 35% of healthcare providers planning to increase ASC adoption.

RESTRAINTS

"Regulatory and compliance barriers"

About 40% of ASCs face operational delays due to strict compliance requirements. Additionally, nearly 32% of new centers report extended licensing approval times, which slows down the overall expansion rate in competitive regions.

CHALLENGE

"Staffing shortages and cost pressures"

Over 55% of ASC operators identify nurse shortages as a critical challenge. Furthermore, nearly 38% of centers experience higher operational costs due to staffing and equipment upgrades, impacting service accessibility in emerging markets.

Segmentation Analysis

The Global Ambulatory Surgery Centers Market size was USD 142.24 Billion in 2024 and is projected to touch USD 150.41 Billion in 2025 to USD 242.08 Billion by 2034, exhibiting a CAGR of 5.43% during the forecast period. By type, Single Specialty and Multi-Specialty centers dominate the market with varied shares and growth patterns. By application, Ophthalmology, Orthopedics, Gastroenterology, Pain Management/Spinal Injections, and Plastic Surgery remain the primary contributors to market expansion, each holding distinct market shares and growth potential. In 2025, Single Specialty accounted for USD 67.18 Billion with 44.65% share at 4.9% CAGR, while Multi-Specialty contributed USD 83.23 Billion with 55.35% share at 5.8% CAGR. By application, Ophthalmology held USD 36.60 Billion with 24.3% share at 5.5% CAGR, Orthopedics accounted for USD 33.59 Billion with 22.3% share at 5.7% CAGR, Gastroenterology recorded USD 28.78 Billion with 19.1% share at 5.6% CAGR, Pain Management/Spinal Injections achieved USD 26.32 Billion with 17.5% share at 5.2% CAGR, and Plastic Surgery reached USD 25.12 Billion with 16.7% share at 5.1% CAGR.

By Type

Single Specialty

Single Specialty Ambulatory Surgery Centers focus on procedures in a single medical area such as ophthalmology, orthopedics, or gastroenterology. Nearly 45% of global procedures in ASCs are handled by single-specialty facilities due to operational efficiency and focused expertise. Their cost-effectiveness and patient-centric care contribute strongly to their expansion.

Single Specialty held the largest share in the Ambulatory Surgery Centers Market, accounting for USD 67.18 Billion in 2025, representing 44.65% of the total market. This segment is expected to grow at a CAGR of 4.9% from 2025 to 2034, driven by rising outpatient surgical volumes, technological adoption, and higher patient preference.

Top 3 Major Dominant Countries in the Single Specialty Segment

• United States led the Single Specialty segment with a market size of USD 22.60 Billion in 2025, holding a 33.6% share and expected to grow at a CAGR of 5.0% due to higher outpatient care adoption and advanced surgical technologies.
• Germany led the Single Specialty segment with a market size of USD 13.45 Billion in 2025, holding a 20.0% share and expected to grow at a CAGR of 4.7% driven by strong orthopedic and ophthalmology procedures.
• Japan led the Single Specialty segment with a market size of USD 10.10 Billion in 2025, holding a 15.0% share and expected to grow at a CAGR of 4.8% due to aging population and rising minimally invasive surgeries.

Multi-Specialty

Multi-Specialty Ambulatory Surgery Centers provide a wider range of surgical services across multiple disciplines. Over 55% of all ASC procedures are carried out in multi-specialty centers, supported by diversified capabilities and cross-specialty patient demand. Their broader service portfolio makes them essential to healthcare accessibility.

Multi-Specialty accounted for USD 83.23 Billion in 2025, representing 55.35% of the total Ambulatory Surgery Centers Market. This segment is projected to expand at a CAGR of 5.8% during 2025–2034, driven by integration of multiple specialties, cost reduction in bundled services, and patient convenience.

Top 3 Major Dominant Countries in the Multi-Specialty Segment

• United States led the Multi-Specialty segment with a market size of USD 28.70 Billion in 2025, holding a 34.5% share and expected to grow at a CAGR of 5.9% due to increasing adoption of integrated surgical centers.
• China led the Multi-Specialty segment with a market size of USD 15.60 Billion in 2025, holding a 18.7% share and expected to grow at a CAGR of 6.1% driven by healthcare reforms and strong demand for outpatient surgeries.
• India led the Multi-Specialty segment with a market size of USD 11.55 Billion in 2025, holding a 13.9% share and expected to grow at a CAGR of 6.3% supported by rising medical infrastructure and affordable surgical care.

By Application

Ophthalmology

Ophthalmology ASCs dominate eye-related surgical procedures such as cataract and LASIK operations. Nearly 24% of global ASC volumes come from ophthalmology due to higher prevalence of vision disorders and growing aging populations worldwide.

Ophthalmology held a market size of USD 36.60 Billion in 2025, representing 24.3% of the total market. This segment is projected to expand at a CAGR of 5.5% during 2025–2034, driven by rising cataract cases, aging demographics, and advanced laser technologies.

Top 3 Major Dominant Countries in the Ophthalmology Segment

• United States led the Ophthalmology segment with a market size of USD 11.25 Billion in 2025, holding a 30.7% share and expected to grow at a CAGR of 5.6% due to high cataract surgical volumes.
• India led the Ophthalmology segment with a market size of USD 8.05 Billion in 2025, holding a 22.0% share and expected to grow at a CAGR of 5.8% due to high prevalence of vision impairments.
• China led the Ophthalmology segment with a market size of USD 7.55 Billion in 2025, holding a 20.6% share and expected to grow at a CAGR of 5.7% due to large patient pools and rising access to eye care.

Orthopedics

Orthopedic ASCs perform joint replacement, spine surgeries, and fracture management. Nearly 22% of total ASC procedures belong to orthopedics, reflecting strong demand from aging populations and sports-related injuries.

Orthopedics accounted for USD 33.59 Billion in 2025, representing 22.3% of the Ambulatory Surgery Centers Market. This segment is expected to grow at a CAGR of 5.7% through 2034, supported by growth in minimally invasive joint and spinal surgeries.

Top 3 Major Dominant Countries in the Orthopedics Segment

• United States led the Orthopedics segment with a market size of USD 10.20 Billion in 2025, holding a 30.4% share and expected to grow at a CAGR of 5.9% due to higher joint replacement procedures.
• Germany led the Orthopedics segment with a market size of USD 7.40 Billion in 2025, holding a 22.0% share and expected to grow at a CAGR of 5.6% driven by advanced surgical practices.
• Japan led the Orthopedics segment with a market size of USD 5.95 Billion in 2025, holding a 17.7% share and expected to grow at a CAGR of 5.5% supported by rising elderly care demand.

Gastroenterology

Gastroenterology ASCs handle procedures like colonoscopies and endoscopies. Nearly 19% of ASC procedures are related to digestive health due to high prevalence of gastrointestinal disorders globally.

Gastroenterology recorded USD 28.78 Billion in 2025, representing 19.1% of the total market. This segment is set to grow at a CAGR of 5.6% through 2034, driven by preventive screenings and rising awareness of gastrointestinal health.

Top 3 Major Dominant Countries in the Gastroenterology Segment

• United States led the Gastroenterology segment with a market size of USD 9.10 Billion in 2025, holding a 31.6% share and expected to grow at a CAGR of 5.7% due to higher adoption of colonoscopy screenings.
• China led the Gastroenterology segment with a market size of USD 7.25 Billion in 2025, holding a 25.2% share and expected to grow at a CAGR of 5.9% supported by rising gastrointestinal disorders.
• Brazil led the Gastroenterology segment with a market size of USD 5.00 Billion in 2025, holding a 17.4% share and expected to grow at a CAGR of 5.5% due to increasing diagnostic awareness.

Pain Management/Spinal Injections

Pain Management ASCs specialize in spinal injections and chronic pain treatment. Nearly 18% of ASC procedures fall in this category, influenced by rising cases of back pain and musculoskeletal conditions.

Pain Management/Spinal Injections achieved USD 26.32 Billion in 2025, representing 17.5% of the market. This segment is anticipated to grow at a CAGR of 5.2% through 2034, driven by increasing demand for non-invasive pain relief procedures.

Top 3 Major Dominant Countries in the Pain Management/Spinal Injections Segment

• United States led the Pain Management segment with a market size of USD 8.60 Billion in 2025, holding a 32.7% share and expected to grow at a CAGR of 5.3% due to high prevalence of chronic pain cases.
• Canada led the Pain Management segment with a market size of USD 5.95 Billion in 2025, holding a 22.6% share and expected to grow at a CAGR of 5.1% supported by advanced healthcare infrastructure.
• United Kingdom led the Pain Management segment with a market size of USD 4.20 Billion in 2025, holding a 15.9% share and expected to grow at a CAGR of 5.0% due to rising patient demand for outpatient pain management.

Plastic Surgery

Plastic Surgery ASCs provide cosmetic and reconstructive procedures. Around 17% of ASC procedures globally are in this category, fueled by growing cosmetic awareness and increased patient affordability.

Plastic Surgery reached USD 25.12 Billion in 2025, representing 16.7% of the Ambulatory Surgery Centers Market. This segment is estimated to grow at a CAGR of 5.1% through 2034, supported by rising aesthetic trends and advancements in cosmetic procedures.

Top 3 Major Dominant Countries in the Plastic Surgery Segment

• United States led the Plastic Surgery segment with a market size of USD 9.45 Billion in 2025, holding a 37.6% share and expected to grow at a CAGR of 5.2% due to higher cosmetic surgery demand.
• South Korea led the Plastic Surgery segment with a market size of USD 7.30 Billion in 2025, holding a 29.1% share and expected to grow at a CAGR of 5.3% due to global leadership in cosmetic procedures.
• Brazil led the Plastic Surgery segment with a market size of USD 4.70 Billion in 2025, holding a 18.7% share and expected to grow at a CAGR of 5.0% driven by increasing demand for reconstructive and aesthetic surgeries.

Ambulatory Surgery Centers Market Regional Outlook

The Global Ambulatory Surgery Centers Market size was USD 142.24 Billion in 2024 and is projected to touch USD 150.41 Billion in 2025 to USD 242.08 Billion by 2034, exhibiting a CAGR of 5.43% during the forecast period. Regionally, North America accounted for 40% share, Europe held 28%, Asia-Pacific represented 22%, and Middle East & Africa captured 10%. Each region demonstrates unique growth drivers shaped by healthcare infrastructure, demographics, and adoption of outpatient surgical services.

North America

North America dominates the Ambulatory Surgery Centers Market with over 60% of outpatient surgical procedures now performed outside hospitals. Rising demand for minimally invasive techniques has led to 48% of orthopedic and 52% of ophthalmology surgeries shifting to ASCs in the region. Patient preference is also higher, with nearly 68% of patients opting for ASCs over traditional hospital settings.

North America held the largest share in the Ambulatory Surgery Centers Market, accounting for USD 60.16 Billion in 2025, representing 40% of the total market. This region continues to expand due to high insurance coverage, improved infrastructure, and a surge in day-care surgical procedures.

North America - Major Dominant Countries in the Ambulatory Surgery Centers Market

• United States led North America with a market size of USD 41.11 Billion in 2025, holding a 68.3% share driven by advanced infrastructure and high outpatient volumes.
• Canada recorded USD 11.42 Billion in 2025, representing an 18.9% share due to improved accessibility and growth in orthopedic surgeries.
• Mexico accounted for USD 7.63 Billion in 2025, holding a 12.8% share supported by rising demand for affordable outpatient procedures.

Europe

Europe shows steady adoption of ambulatory surgery with more than 55% of cataract and 42% of endoscopy procedures conducted in ASCs. Around 46% of patients prefer outpatient centers to hospitals, reflecting growing demand for efficient, cost-effective healthcare solutions. The region’s market is driven by public-private healthcare collaborations.

Europe accounted for USD 42.11 Billion in 2025, representing 28% of the global Ambulatory Surgery Centers Market. Strong emphasis on reducing hospital burdens and advancing outpatient facilities is pushing adoption rates higher across the region.

Europe - Major Dominant Countries in the Ambulatory Surgery Centers Market

• Germany led Europe with a market size of USD 12.85 Billion in 2025, holding a 30.5% share, driven by rising demand for ophthalmic and orthopedic ASCs.
• United Kingdom registered USD 11.23 Billion in 2025, capturing a 26.7% share due to growing minimally invasive procedure adoption.
• France accounted for USD 9.45 Billion in 2025, holding a 22.5% share supported by strong government-backed ASC initiatives.

Asia-Pacific

Asia-Pacific is emerging as a high-growth market with 38% of outpatient surgical demand coming from ophthalmology and 33% from orthopedics. Nearly 54% of patients in urban centers prefer ASCs due to affordability and faster recovery. Rapid medical infrastructure expansion and rising healthcare spending are fueling growth across the region.

Asia-Pacific represented USD 33.09 Billion in 2025, accounting for 22% of the global Ambulatory Surgery Centers Market. Strong expansion is driven by an increasing patient base, affordable care options, and adoption of minimally invasive technologies.

Asia-Pacific - Major Dominant Countries in the Ambulatory Surgery Centers Market

• China led Asia-Pacific with a market size of USD 12.55 Billion in 2025, holding a 37.9% share due to rapid ASC infrastructure development.
• India accounted for USD 9.28 Billion in 2025, representing 28.0% share driven by rising urban population and growing surgical demand.
• Japan registered USD 7.62 Billion in 2025, holding a 23.0% share due to strong adoption of advanced minimally invasive procedures.

Middle East & Africa

Middle East & Africa is steadily advancing in the ASC sector, with nearly 25% of outpatient surgeries now performed outside hospitals. Orthopedics and ophthalmology account for over 46% of ASC volumes, with patient preference for shorter recovery times growing by 31% in recent years.

Middle East & Africa accounted for USD 15.05 Billion in 2025, representing 10% of the global Ambulatory Surgery Centers Market. Growth is supported by government healthcare reforms, medical tourism, and rising adoption of outpatient surgeries in urban centers.

Middle East & Africa - Major Dominant Countries in the Ambulatory Surgery Centers Market

• United Arab Emirates led Middle East & Africa with a market size of USD 5.10 Billion in 2025, holding a 33.9% share due to strong medical tourism and ASC infrastructure.
• South Africa registered USD 4.65 Billion in 2025, capturing a 30.9% share with rising orthopedic procedures.
• Saudi Arabia accounted for USD 3.95 Billion in 2025, holding a 26.2% share driven by expanding healthcare reforms and ASC adoption.

List of Key Ambulatory Surgery Centers Market Companies Profiled

Investment Analysis and Opportunities in Ambulatory Surgery Centers Market

Investments in the Ambulatory Surgery Centers Market are rising due to shifting surgical procedures from inpatient to outpatient settings. Nearly 62% of investors prefer multi-specialty ASCs because of their diversified service portfolios. Around 48% of new funding is allocated to technology integration, including advanced imaging and robotic-assisted surgeries. Approximately 52% of venture capital firms are focusing on digital transformation within ASCs, aiming to improve efficiency and patient outcomes. Additionally, nearly 45% of healthcare providers highlight expansion into rural and underserved areas as the most promising investment opportunity, while 38% focus on cross-border partnerships to capture global demand. The overall environment suggests that opportunities are strong for both infrastructure upgrades and specialized procedural expansions.

New Products Development

New product development in the Ambulatory Surgery Centers Market is accelerating with a strong focus on digital and minimally invasive solutions. Nearly 47% of ASCs are integrating AI-based patient monitoring systems, while 41% are adopting advanced surgical robotics. Around 35% of manufacturers are focusing on innovative pain management devices to reduce opioid dependency post-surgery. Moreover, 52% of centers are upgrading their operating rooms with next-generation imaging technologies, enabling real-time precision in surgical outcomes. Nearly 44% of new launches focus on ophthalmology and orthopedic tools, reflecting high demand for specialized procedures. These advancements highlight the sector’s commitment to efficiency, safety, and improved patient satisfaction.

Recent Developments

• Epic Systems partnership expansion: In 2024, Epic Systems expanded partnerships with more than 22% of ASCs globally, enabling deeper integration of electronic health records and improving patient data accessibility.
• Cerner digital upgrades: Cerner Corporation introduced advanced cloud-based ASC management software adopted by 18% of new centers, enhancing scheduling and operational efficiency in outpatient surgeries.
• GE Healthcare innovation: GE Healthcare rolled out AI-powered imaging solutions, which have been deployed in over 20% of ophthalmology-focused ASCs, improving diagnostic precision in surgical settings.
• Philips remote care technology: Philips Healthcare launched telehealth monitoring tools in 2024, with adoption across 15% of ASC facilities, enhancing pre- and post-surgery patient engagement.
• Allscripts integration success: Allscripts Healthcare Solutions integrated advanced analytics platforms in 12% of multi-specialty ASCs, enabling performance tracking and boosting patient outcome efficiency by nearly 25%.

Report Coverage

The Ambulatory Surgery Centers Market report provides comprehensive insights into the evolving landscape of outpatient surgical care. It highlights segmentation by type, including single specialty centers with 44.6% share and multi-specialty centers with 55.3% share in 2025. Application analysis covers ophthalmology at 24.3%, orthopedics at 22.3%, gastroenterology at 19.1%, pain management at 17.5%, and plastic surgery at 16.7%. Regional outlook shows North America leading with 40% share, followed by Europe at 28%, Asia-Pacific at 22%, and Middle East & Africa at 10%. The report also profiles ten major companies, including Epic Systems, Cerner Corporation, and GE Healthcare, with top two players holding nearly 30% combined market share. Additionally, investment trends reveal that 62% of funding flows into multi-specialty centers, while 48% is directed toward technology integration. Product innovations such as AI-powered monitoring systems (47% adoption) and robotics (41% adoption) are highlighted as major growth drivers. The report ensures stakeholders have detailed insights into current trends, restraints, opportunities, challenges, and future prospects of the ASC market.